Abstract
Intracellular antibodies (intrabodies) are antibody molecules which are expressed intracellularly and which are located in defined subcellular compartments, for example, the endoplasmic reticulum (ER). The amount of any surface protein (target protein) on a mammalian cell can be downregulated significantly by transfection with an expression vector encoding the intrabody that is specific for the target protein. To analyze the phenotypic knockdown of the target protein, either flow cytometry or fluorescence microscopy can be applied. In this article, we provide detailed protocols for both methods.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beerli RR, Wels W, Hynes NE (1994) Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J Biol Chem 269(39):23931–23936
Böldicke (2007) Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER. J Cell Mol Med 11(1):54–70
Kontermann RE (2004) Intrabodies as therapeutic agents. Methods (San Diego, CA) 34(2):163–170
Paganetti P, Calanca V, Galli C, Stefani M, Molinari M (2005) beta-site specific intrabodies to decrease and prevent generation of Alzheimer’s Abeta peptide. J Cell Biol 168(6):863–868
Persic L, Righi M, Roberts A, Hoogenboom HR, Cattaneo A, Bradbury A (1997) Targeting vectors for intracellular immunisation. Gene 187(1):1–8
Rondon IJ, Marasco WA (1997) Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu Rev Microbiol 51:257–283
Strebe N, Guse A, Schüngel M, Schirrmann T, Hafner M, Jostock T, Hust M, Müller W, Dübel S (2009) Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodies. J Immunol Methods 341:30–40
Zhan J, Stayton P, Press OW (1998) Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation. Cancer Immunol, Immunother: CII 46(1):55–60
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this protocol
Cite this protocol
Strebe, N., Schüngel, M. (2010). Phenotypic Knockdown with Intrabodies. In: Kontermann, R., Dübel, S. (eds) Antibody Engineering. Springer Protocols Handbooks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01147-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-01147-4_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01146-7
Online ISBN: 978-3-642-01147-4
eBook Packages: Springer Protocols